Neuropace (NPCE) had the highest return between January 2, 2023 and February 28, 2023 by a small-cap US stock, returning 271.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Neuropace (NPCE) | 1/2/2023 - 2/28/2023 | 271.74% |
Selectquote (SLQT) | 1/2/2023 - 2/28/2023 | 246.15% |
NGL Energy Partners (NGL) | 1/2/2023 - 2/28/2023 | 199.13% |
Clene (CLNNW) | 1/2/2023 - 2/28/2023 | 197.5% |
Sky Harbour (SKYH) | 1/2/2023 - 2/28/2023 | 150.51% |
Bitfarms (BITF) | 1/2/2023 - 2/28/2023 | 117.89% |
Nerdwallet (NRDS) | 1/2/2023 - 2/28/2023 | 112.56% |
Dianthus Therapeutics (DNTH) | 1/2/2023 - 2/28/2023 | 108.07% |
So-Young International (SY) | 1/2/2023 - 2/28/2023 | 105% |
Manitowoc (MTW) | 1/2/2023 - 2/28/2023 | 103.77% |
American Battery Technology Company Common Stock (ABAT) | 1/2/2023 - 2/28/2023 | 103.39% |
Bit Digital (BTBT) | 1/2/2023 - 2/28/2023 | 103.23% |
GD Culture (GDC) | 1/2/2023 - 2/28/2023 | 101.67% |
Qilian International (BGM) | 1/2/2023 - 2/28/2023 | 97.46% |
Yirendai (YRD) | 1/2/2023 - 2/28/2023 | 96.32% |
Redwire (RDW) | 1/2/2023 - 2/28/2023 | 94% |
HIVE Blockchain Technologies (HIVE) | 1/2/2023 - 2/28/2023 | 91.28% |
Intuitive Machines (LUNR) | 1/2/2023 - 2/28/2023 | 90.52% |
Immunome (IMNM) | 1/2/2023 - 2/28/2023 | 90.42% |
Blue Bird (BLBD) | 1/2/2023 - 2/28/2023 | 87.36% |
GCM Grosvenor (GCMGW) | 1/2/2023 - 2/28/2023 | 85.47% |
MoonLake Immunotherapeutics (MLTX) | 1/2/2023 - 2/28/2023 | 81.04% |
Universal Insurance (UVE) | 1/2/2023 - 2/28/2023 | 80.82% |
Navitas Semiconductor (NVTS) | 1/2/2023 - 2/28/2023 | 80.78% |
Skywater Technology (SKYT) | 1/2/2023 - 2/28/2023 | 80.11% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
